Scoop: Metagenomi is preparing for an IPO this fall, in what could jumpstart a wave of public offerings
Gene-editing biotech Metagenomi is preparing to go public and is working with the investment bank JP Morgan on a potential listing this fall, according to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.